Expression and clinical significance of cancerous inhibitor of protein phosphatase 2A （CIP2A） in human ovarian cancers tissues.
LI Zheng-tao，FANG Yuan-yuan.
Chinese Journal of Practical Gynecology and Obstetrics ›› 2015, Vol. 31 ›› Issue (6) : 552-555.
Expression and clinical significance of cancerous inhibitor of protein phosphatase 2A （CIP2A） in human ovarian cancers tissues.
Abstract： Objective To investigate expression and clinical significance of CIP2A in ovarian cancer tissues.
［1］ Junttila MR，Puustinen P，Niemelä M，et al. CIP2A inhibits PP2A in human malignancies［J］. Cell，2007，130（1）: 51-62.
［2］ Dong QZ，Wang Y，Dong XJ，et al. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis［J］. Ann Surg Oncol，2011，18（3）: 857-865.
［3］ Côme C，Laine A，Chanrion M，et al.CIP2A is associated with human breast cancer aggressivity［J］. Clin Cancer Res，2009，15（16）: 5092-5100.
［4］ Böckelman C，Hagström J，Mäkinen LK，et al. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer［J］. Br J Cancer，2012，104（12）: 1890-1895.
［5］ Guo Z，Liu D，Su Z. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway［J］. Tumour Biol，2015，［Epub ahead of print］
［6］ Huang J，Jia J，Tong Q，et al. Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy［J］. Tumour Biol，2015,36(3):1589-1594.
［7］ Schwartz DR，Kardia SL，Shedden KA，et al. Gene expression in ovarian cancer reflects both morphology and biological behavior，distinguishing clear cell from other poor-prognosis ovarian carcinomas［J］. Cancer Res，2002，62（16）: 4722-4729.
［8］ Zorn KK，Bonome T，Gangi L，et al. Gene expression profiles of serous，endometrioid，and clear cell subtypes of ovarian and endometrial cancer［J］. Clin Cancer Res，2005，11（18）: 6422-6430.
［9］. De P，Carlson J，Leyland-Jones B，et al. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A （CIP2A）: an oncoprotein with many hands［J］. Oncotarget，2014，5（13）:4581-4602.
［10］ Kim A，Ueda Y，Naka T，et al. Therapeutic strategies in epithelial ovarian cancer［J］. J Exp Clin Cancer Res，2012，31: 14.
（2015-01-03收稿 2015-03-20修回）
/
| 〈 |
|
〉 |
